IDiyas

For the Inventor, By the Inventor

Paris, France

Pierre Etienne Chabrier De Lassauniere

USPTO Granted Patents = 12


Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:

goldMedal11 out of 119 
 
Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.)
 patents
silverMedal1 out of 3 
 
Societe De Conseils De Recherches Et D'applications (s.c.r.a.s.)
 patents

Years Active: 1999-2009

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 7553976 - Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2009-06-30),
2. 7459558 - Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2008-12-02),
3. 7122535 - Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2006-10-17),
4. 6809088 - Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2004-10-26),
5. 6630461 - Derivatives of 2-(iminomethyl) amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2003-10-07),
6. 6599903 - Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2003-07-29),
7. 6586454 - Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2003-07-01),
8. 6340700 - 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same (2002-01-22),
9. 6335445 - Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2002-01-01),
10. 6300499 - &agr;1-adrenergic receptor antagonists (2001-10-09),
11. 6063807 - Cyclo-oxygenase inhibitor and amidine derivatives salts, preparation (2000-05-16),
12. 5972940 - Arginine analogues having nitric oxide synthase inhibitor activity (1999-10-26),

Title: **Pierre Etienne Chabrier De Lassauniere: Innovating Medicaments in Paris**

Introduction

Pierre Etienne Chabrier De Lassauniere is a prominent inventor based in Paris, France, known for his significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 12 patents, he has dedicated his research to developing innovative pharmaceuticals aimed at treating severe medical conditions.

Latest Patents

His latest patents focus on the development of derivatives of 2-(iminomethyl)amino-phenyl. These compounds serve as NO synthase inhibitors and have the potential to trap reactive oxygen species. The inventions outline their preparation and pharmaceutical compositions, indicating their utility in treating conditions such as stroke, neurodegenerative diseases, and ischemic or hemorrhagic cardiac or cerebral infarctions. A method of treatment involving these compounds is designed for administration to warm-blooded animals in need of such medicinal intervention, showcasing their therapeutic potential.

Career Highlights

Pierre has significantly impacted the pharmaceutical industry through his work with esteemed organizations. He has collaborated with Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS), focusing on innovative research and development. His career reflects a deep commitment to advancing medical science through inventiveness and resourceful applications.

Collaborations

Throughout his career, Pierre has worked alongside notable colleagues such as Serge Auvin and Dennis Bigg. These collaborations have facilitated knowledge sharing and innovation in medicinal research, contributing to the successful development of his patented compounds.

Conclusion

Pierre Etienne Chabrier De Lassauniere stands out as a key figure in the innovation of pharmaceutical sciences. His dedication to creating impactful medicaments exemplifies the spirit of invention that drives advancements in healthcare. Through his exceptional patents and collaborative efforts, he continues to influence the field, improving treatment options for critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…